Competition Commission of India (CCI) approves Scheme of Arrangement between Strides Shasun, Sequent Scientific and Solara Active Pharma Sciences. In an interview to CNBC-TV18, Manish Gupta, CEO of Sequent Scientific spoke about the same.
In an interview to CNBC-TV18, Manish Gupta, CEO of Sequent Scientific spoke about the same.“We have also filed for stock exchanges approvals which is imminent and thereafter we have to approach the National Company Law Tribunal (NCLT). We should initiate the process with NCLT by end of July,” he said.
He expects delays in the process and foresees about three months for the entire process to go through from NCLT perspective followed by the stock exchange which will be a couple of weeks exercise.
Listing should occur by December or latest by January, he believes.